JP2009523730A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523730A5
JP2009523730A5 JP2008550444A JP2008550444A JP2009523730A5 JP 2009523730 A5 JP2009523730 A5 JP 2009523730A5 JP 2008550444 A JP2008550444 A JP 2008550444A JP 2008550444 A JP2008550444 A JP 2008550444A JP 2009523730 A5 JP2009523730 A5 JP 2009523730A5
Authority
JP
Japan
Prior art keywords
tanshinone
disease
mammal
sepsis
septicemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008550444A
Other languages
English (en)
Japanese (ja)
Other versions
JP5247469B2 (ja
JP2009523730A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/000945 external-priority patent/WO2007084419A2/en
Publication of JP2009523730A publication Critical patent/JP2009523730A/ja
Publication of JP2009523730A5 publication Critical patent/JP2009523730A5/ja
Application granted granted Critical
Publication of JP5247469B2 publication Critical patent/JP5247469B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008550444A 2006-01-13 2007-01-12 タンシノンを用いた炎症性サイトカイン産生の阻害 Expired - Fee Related JP5247469B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75923706P 2006-01-13 2006-01-13
US60/759,237 2006-01-13
PCT/US2007/000945 WO2007084419A2 (en) 2006-01-13 2007-01-12 Inhibition of inflammatory cytokine production with tanshinones

Publications (3)

Publication Number Publication Date
JP2009523730A JP2009523730A (ja) 2009-06-25
JP2009523730A5 true JP2009523730A5 (cg-RX-API-DMAC7.html) 2013-02-28
JP5247469B2 JP5247469B2 (ja) 2013-07-24

Family

ID=38288155

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550444A Expired - Fee Related JP5247469B2 (ja) 2006-01-13 2007-01-12 タンシノンを用いた炎症性サイトカイン産生の阻害

Country Status (7)

Country Link
US (1) US8513227B2 (cg-RX-API-DMAC7.html)
EP (1) EP1981489B1 (cg-RX-API-DMAC7.html)
JP (1) JP5247469B2 (cg-RX-API-DMAC7.html)
CN (1) CN101394860B (cg-RX-API-DMAC7.html)
AU (1) AU2007207675B2 (cg-RX-API-DMAC7.html)
CA (1) CA2636909A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007084419A2 (cg-RX-API-DMAC7.html)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101327249B (zh) * 2007-06-21 2012-07-18 天津天士力制药股份有限公司 二羟基苯基乳酸在制备治疗败血症的药物中的应用
WO2010088786A1 (zh) * 2009-02-06 2010-08-12 Lin Xiuying 具有cox-2和免疫活性的草药组合物及其制备方法
CN106367478A (zh) 2009-12-22 2017-02-01 雅芳产品公司 桩蛋白刺激组合物及其化妆品用途
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
DK2365332T3 (da) * 2010-03-10 2013-08-26 Pasteur Institut HMGB1- og anti-HMGB1-antistoffer i HIV-inficerede patienter, især med neurologiske lidelser
US9244074B2 (en) * 2011-06-07 2016-01-26 University Of Hawaii Biomarker of asbestos exposure and mesothelioma
US9561274B2 (en) 2011-06-07 2017-02-07 University Of Hawaii Treatment and prevention of cancer with HMGB1 antagonists
CN102949399B (zh) * 2011-08-23 2016-02-24 上海中医药大学附属岳阳中西医结合医院 丹参酮iia在制备抑制角质形成细胞增殖疾病药中的应用
KR101612051B1 (ko) * 2011-12-20 2016-04-27 한국생명공학연구원 단삼 추출물을 포함하는 코로나 바이러스 감염의 예방 또는 치료용 조성물
KR101400900B1 (ko) * 2012-01-26 2014-05-29 한국생명공학연구원 탄시논을 유효성분으로 함유하는 자연살해세포 분화 또는 활성 증진용 조성물
CN102670768A (zh) * 2012-05-15 2012-09-19 宋协勘 一种治疗急性阑尾炎的中药
CN102824349A (zh) * 2012-09-14 2012-12-19 广东省中医院 丹参酮ⅱa在制备治疗银屑病药物中的应用
CN102973575A (zh) * 2012-11-23 2013-03-20 广东省中医院 隐丹参酮在制备治疗银屑病药物中的应用
CN103006549B (zh) * 2012-12-05 2015-04-15 广东宏远集团药业有限公司 采用助溶消泡溶剂制备丹参酮iia磺酸钠制剂的方法
CN103040837A (zh) * 2013-01-13 2013-04-17 广东宏盈科技有限公司 一种眼科外用降眼压药物
GB201312205D0 (en) * 2013-07-08 2013-08-21 Univ Leuven Kath Anticonvulsant activity of dan shen extracting compounds
KR20170006030A (ko) * 2015-07-07 2017-01-17 재단법인 진안홍삼연구소 크립토탄시논을 유효성분으로 포함하는 구강세균 독성에 의한 염증을 예방, 개선 또는 치료하는 조성물
CN105168222A (zh) * 2015-07-23 2015-12-23 南京赋海澳赛医药科技有限公司 组合物及其在抗鼻炎药物中的应用
WO2017070421A1 (en) * 2015-10-22 2017-04-27 The Feinstein Institute For Medical Research Use of dermcidin in sterile inflammatory conditions
CN108264515B (zh) * 2017-01-04 2021-01-12 中国科学院上海药物研究所 一类苯并[def]咔唑类化合物及其制备方法和应用
CN106924740A (zh) * 2017-03-15 2017-07-07 河南科技大学 一种治疗急性肺损伤的药物组合物
CN106963776A (zh) * 2017-04-26 2017-07-21 上海市疾病预防控制中心 一种化合物在制备以组织蛋白酶k为靶标的疾病药中的应用
CN108785314A (zh) * 2017-05-03 2018-11-13 阎永平 用于治疗和预防酒精性肝病的药物及其组合物
PL3773537T3 (pl) 2018-04-19 2022-05-23 Tvardi Therapeutics, Inc. Inhibitory stat3
US11026905B2 (en) 2018-04-19 2021-06-08 Tvardi Therapeutics, Inc. STAT3 inhibitors
CN108837001A (zh) * 2018-07-20 2018-11-20 深圳市博奥生物科技有限公司 一种三七丹参片及其制备方法
CN108685981A (zh) * 2018-07-20 2018-10-23 深圳市博奥生物科技有限公司 一种三七丹参胶囊及其制备方法
EP3873458A4 (en) * 2018-11-02 2022-07-06 University of Maryland, Baltimore TYPE 3 SECRETION SYSTEM INHIBITORS AND ANTIBIOTIC THERAPY
CN115052584B (zh) 2020-01-24 2024-08-23 特维迪疗法公司 治疗性化合物及其制剂和用途
CN111166754A (zh) * 2020-02-25 2020-05-19 上海市第六人民医院 隐丹参酮在制备防治恶病质骨骼肌萎缩药物中的应用
CN111214467A (zh) * 2020-03-05 2020-06-02 南京巴傲得生物科技有限公司 吲哚布洛芬在抵抗hmgb1促炎活性中的应用
CN113679726B (zh) * 2020-05-18 2025-01-10 上海科技大学 丹参提取物和醌类化合物在抗冠状病毒中的应用
CN116098060A (zh) * 2020-06-10 2023-05-12 甘肃省农业科学院经济作物与啤酒原料研究所(甘肃省农业科学院中药材研究所) 一种当归组培苗生根培养方法
CN115025103A (zh) * 2021-03-04 2022-09-09 上海上药第一生化药业有限公司 丹参酮iia磺酸钠在制备药物中的应用
CN113005130B (zh) * 2021-03-18 2022-07-08 上海辰山植物园 丹参酮ⅱa合酶基因及应用
AU2023292912A1 (en) 2022-06-15 2025-01-16 Tvardi Operating Company, Inc. Prodrugs of stat3 inhibitors
CN117986316A (zh) * 2022-11-02 2024-05-07 广州中大南沙科技创新产业园有限公司 丹参中总丹参酮的提取方法及其应用
CN117442626A (zh) * 2023-09-22 2024-01-26 浙江大学绍兴研究院 隐丹参酮在防治人巨细胞病毒感染中的新用途
CN119950521A (zh) * 2025-01-14 2025-05-09 浙江工业大学 丹参酮i在制备治疗艾滋病的药物中的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0830077B2 (ja) * 1987-04-24 1996-03-27 晟 八木 虚血性疾患治療剤
CN1304723A (zh) * 2001-01-16 2001-07-25 中山大学 含二氢呋喃环结构的丹参酮类化合物用于治疗肝性脑病的药物
CN1251718C (zh) * 2003-05-13 2006-04-19 天津红日药业股份有限公司 一种预防、治疗脓毒症的中药复方制剂及其制备方法
WO2005063232A1 (en) * 2003-12-30 2005-07-14 Md Bioalpha Co., Ltd. Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity
KR100725839B1 (ko) * 2005-10-06 2007-12-11 일성신약주식회사 단삼으로부터 분리된 탄시논류의 화합물을 함유하는인지기능 장애의 예방 및 치료용 조성물

Similar Documents

Publication Publication Date Title
JP6933690B2 (ja) 多環式カルバモイルピリドン化合物およびその薬学的用途
CA2769553A1 (en) Novel pyrimidine and triazine hepcidin antagonists
SI2860251T1 (en) Aptameric therapeutics useful in the treatment of complement-related disorders
EP3870578B1 (en) Therapeutic compounds
CA2575777A1 (en) Compositions and methods for treatment of colitis using methimazole and/or cyclic thione derivatives
US11517565B2 (en) Bis-amines, compositions, and uses related to CXCR4 inhibition
MA34400B1 (fr) Dérivés d'acide 2-quinolinyl-acétique en tant que composés antiviraux contre le vih
JP2015518902A5 (cg-RX-API-DMAC7.html)
JP2014510746A5 (cg-RX-API-DMAC7.html)
EA200970852A1 (ru) Производные пиразоло[3,4-в]пиридина в качестве ингибиторов фосфодиэстеразы
JP2016540749A5 (cg-RX-API-DMAC7.html)
WO2015175855A1 (en) Chemokine cxcr4 and ccr5 receptor modulators and used related thereto
EA200900472A1 (ru) Ингибиторы фосфодиэстеразы iv типа
JP7452881B2 (ja) 心血管疾患の処置に有用な新規化合物
CN107793409B (zh) 二氢嘧啶类化合物及其在药物中的应用
TW202327622A (zh) 用於治療與呼吸道病毒感染相關的細胞介素釋放相關病症的irak抑制劑
WO2009129094A3 (en) Combinations of antiviral agents and other compounds
TWI627955B (zh) β-咔啉生物鹼於抑制黃嘌呤氧化酶活性之用途
EP3429588B1 (en) Amide-sulfamide derivatives, compositions, and uses related to cxcr4 inhibition
CN108349945B (zh) Hcv抑制剂、其制备方法与应用
HK40109401A (en) Deuterated 5-phenylpiperidine-2-ketone compound and use thereof
JPWO2022203082A5 (cg-RX-API-DMAC7.html)
OA17631A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use.